A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/25/2011	US8044211 P38 MAP kinase inhibitors
10/25/2011	US8044210 Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof
10/25/2011	US8044209 Pyrrolydine derivatives as IAP inhibitors
10/25/2011	US8044207 Pyridinoylpiperidines as 5-HT1F agonists
10/25/2011	US8044206 Nitrogen—containing heterocyclic derivatives having 2,6-disubstituted styryl
10/25/2011	US8044204 8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
10/25/2011	US8044202 Azaspiro derivatives
10/25/2011	US8044198 Sirtuin modulating compounds
10/25/2011	US8044195 Cross-linked glycopeptide-cephalosporin antibiotics
10/25/2011	US8044193 Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide
10/25/2011	US8044104 Prostaglandin derivative-containing aqueous liquid preparation
10/25/2011	US8044103 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
10/25/2011	US8044102 administering to animals antibiotic deriavtives such as florfenicol or flunixin meglumine, for prevention of urogenital, respiratory system and gastrointestinal disorders, vision defects and mastitis; veterinary medicine
10/25/2011	US8044101 Nitrosation-inducible inhibitors biological macromolecules
10/25/2011	US8044100 Methods and compositions for treating amyloid-related diseases
10/25/2011	US8044099 conjugates of a drug moiety and a pharmacokinetic modulating moiety, they exhibit at least one modulated pharmacokinetic property such as half-life, hepatic first-pass metabolism, volume of distribution and degree of blood protein binding, upon administering to a host
10/25/2011	US8044098 Use of e.g. 2,4-dihydroxybenzoic acid or 3,4,5-trihydroxybenzoic acid or esters thereof; hepatitis B virus (HBV), papillomavirus and/or herpes virus
10/25/2011	US8044097 Chroman derivatives
10/25/2011	US8044096 Method for treating addiction using quercetin-containing compositions
10/25/2011	US8044095 (-)-epigallocatechina-3-gallato (EGCG); side effect reduction; green tea extract
10/25/2011	US8044094 Agents for preventing and treating disorders connected to impaired neurotransmission
10/25/2011	US8044093 Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
10/25/2011	US8044092 Therapeutic compounds
10/25/2011	US8044091 Phospho-indoles as HIV inhibitors
10/25/2011	US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
10/25/2011	US8044089 3-3-di-substituted-oxindoles as inhibitors of translation initiation
10/25/2011	US8044088 1-acetic acid-indole derivatives with PGD2 antagonist activity
10/25/2011	US8044087 Hepatitis C virus inhibitors
10/25/2011	US8044083 Kinase inhibitors and methods of use thereof
10/25/2011	US8044082 N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof
10/25/2011	US8044081 Aminoderivative of biotin and their conjugates with macrocyclic chelating agents
10/25/2011	US8044080 having the cyclic carboxylic acid hemiketal moiety; treating inflammation or preventing apoptosis; dementia, cerebral stroke, brain impairment
10/25/2011	US8044079 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof
10/25/2011	US8044078 Amino-alkyl amide derivatives as CCR3 receptor ligands
10/25/2011	US8044077 Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
10/25/2011	US8044076 Phenyl derivatives and their use as immunomodulators
10/25/2011	US8044075 IL-8 receptor antagonists
10/25/2011	US8044074 e.g. 1-(2-Cyclopropylmethoxy-1,2-diphenylethyl)-1H-pyridin-2-one; potassium (K+) channel-blocking agent; atrial arrhythmias, such as atrial fibrillation (AF) or atrial flutter; respiratory disorders, neurodegenerative disorders; anticarcinogenic agent
10/25/2011	US8044073 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
10/25/2011	US8044072 Pyrrole derivatives, preparation thereof and therapeutic use thereof
10/25/2011	US8044071 Method for reducing side effects of CB2 receptor agonist therapy using a combination of a selective CB2 receptor agonist and a selective CB1 receptor antagonist
10/25/2011	US8044070 Heteroaryloxy nitrogenous saturated heterocyclic derivative
10/25/2011	US8044069 Compounds as calcium channel blockers
10/25/2011	US8044068 Aminopyrrolidine compound
10/25/2011	US8044067 Isoquinolines as IGF-1R inhibitors
10/25/2011	US8044066 Derivatives of pyrrolopyridine-2-carboxamides, preparation thereof and therapeutic application thereof
10/25/2011	US8044065 Benzothienopyridines for use as inhibitors of Eg5 kinesin
10/25/2011	US8044064 Fused pyrrolocarbazoles
10/25/2011	US8044063 Quinazoline derivatives useful as anti-tumor medicament
10/25/2011	US8044062 Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alpha
10/25/2011	US8044061 8-alkynylxanthines and derivatives
10/25/2011	US8044060 6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
10/25/2011	US8044058 Merocyanine derivatives
10/25/2011	US8044057 Methods for suppressing an immune response or treating a proliferative disorder
10/25/2011	US8044056 Adenine compound
10/25/2011	US8044055 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptor
10/25/2011	US8044054 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/25/2011	US8044053 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
10/25/2011	US8044052 Biaryl ether urea compounds
10/25/2011	US8044051 Methods and compositions for the production of high concentration alloxazine solutions
10/25/2011	US8044050 Imidazo[1,2-a]azines and their use as pharmaceuticals
10/25/2011	US8044049 Fused heterocyclic derivative and use thereof
10/25/2011	US8044048 Derivatives of sulindac, use thereof and preparation thereof
10/25/2011	US8044047 5-substituted benzoxazines
10/25/2011	US8044046 Medicaments for the treatment of chronic obstructive pulmonary disease
10/25/2011	US8044045 Indazole-carboxamide compounds as 5-HT4 receptor agonists
10/25/2011	US8044044 4-(1-amino-ethyl)-cyclohexylamine derivatives
10/25/2011	US8044043 CGRP receptor antagonists
10/25/2011	US8044042 Thienotriazolodiazepine compound and medicinal use thereof
10/25/2011	US8044041 Phthalazine derivatives as inhibitors of protein kinase
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8044039 Quetiapine hemifumarate purification by crystallization
10/25/2011	US8044038 Crystallization process of quetiapine hemifumarate
10/25/2011	US8044037 Modified phosphocalcic compound, injectable composition containing same
10/25/2011	US8044035 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/25/2011	US8044034 Nanoparticle derivatives of gemcitabine
10/25/2011	US8044033 Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer
10/25/2011	US8044031 Method for increasing the survival of aquatic and other animals exposed to an aquatic virus, birnavirus or other RNA virus and composition for such methods
10/25/2011	US8044030 Antibiotic macrocycle compounds and methods of manufacture and use thereof
10/25/2011	US8044029 Sulfatides for treatment of autoimmune disorders
10/25/2011	US8043631 Tumor targeting drug-loaded particles
10/25/2011	US8043630 Shell-and-core dosage form approaching zero-order drug release
10/25/2011	US8043628 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
10/25/2011	US8043626 Fatty acid antimicrobial
10/25/2011	US8043612 Infection and treatment of neoplasms with vesicular stomatitis virus
10/25/2011	US8043607 UV-absorbers for ophthalmic lens materials
10/25/2011	CA2657355C Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
10/25/2011	CA2608163C Hydralazine compositions and methods
10/25/2011	CA2581225C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/25/2011	CA2580910C Pharmaceutical composition comprising temozolomide ester
10/25/2011	CA2536487C Rapid dissolution formulation of a calcium receptor-active compound
10/25/2011	CA2531862C Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
10/25/2011	CA2531454C Use of rapamycin and rapamycin derivatives for the treatment of bone loss
10/25/2011	CA2518299C 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives
10/25/2011	CA2516937C Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one derivatives and theiruse against neurogenerative diseases
10/25/2011	CA2486380C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
10/25/2011	CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/25/2011	CA2454658C Methods for treating joint inflammation, pain, and loss of mobility
10/25/2011	CA2445612C Methods and compositions for treating mammalian nerve tissue injuries
10/25/2011	CA2437983C Transporters comprising spaced arginine moieties

1 ... 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 ... 7860